435 (Acamprosate calcium delayed-release 333 mg)
Pill imprint 435 has been identified as Acamprosate calcium delayed-release 333 mg.
Acamprosate is used in the treatment of alcohol dependence and belongs to the drug class drugs used in alcohol dependence. Risk cannot be ruled out during pregnancy. Acamprosate 333 mg is not a controlled substance under the Controlled Substance Act (CSA).
Acamprosate calcium delayed-release
- Imprint:
- 435
- Strength:
- 333 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Drugs used in alcohol dependence
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Glenmark Generics Inc., USA
More about acamprosate
Consumer resources
- Other brands: Campral
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
